パーキンソン病 の 睡眠 機能 障害 に 対する 皮膚 経,輸液 経,外科 療法 と の 影響
Karolina Popławska-Domaszewicz1, Raslan Ahmed2, Riaan van Coller3
1Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland; Parkinson Foundation Centre of Excellence, King's College Hospital and King's College, London, UK; Honorary Faculty, Parkinson Foundation Centre of Excellence, King's College Hospital London, United Kingdom.
Sleep medicine clinics
|September 5, 2025
まとめ
パーキンソン病患者は ドーパミンの投与で 睡眠障害を患うことが多い. サブタラミック核 (STN) の深部脳刺激 (DBS) のような非口腔治療は,夜間症状と睡眠の質を改善します.
科学分野:
- 神経学
- 睡眠医学
- 運動障害
背景:
- ドーパミンの代用療法を使用するパーキンソン病 (PD) の患者では睡眠機能障害が一般的です.
- 現在の経口療法では,夜間投与は行われず,夜間投与は最適ではない.
- これはPD患者の睡眠障害と生活の質の低下につながる.
研究 の 目的:
- パーキンソン病における睡眠障害の管理のための非経口療法戦略を評価する.
- サブタラミック核 (STN) の深部脳刺激 (DBS) と,他の非経口療法による夜間症状の治療効果を比較する.
- PD患者の客観的および主観的な睡眠パラメータに対するSTN-DBSの影響を評価する.
主な方法:
- パーキンソン病の非経口療法に関する既存の文献と臨床データのレビュー
- PD患者における亜thalamic nucleus (STN) の深い脳刺激 (DBS) を調査した研究の分析.
- パーキンソン病睡眠スケール (PDSS) のような検証されたスケールを用いて睡眠の質の評価
主要な成果:
- 皮膚経由療法や輸液システムを含む非経口療法が,夜間ドーパミナージックサポートを効果的に提供します.
- サブタラミック核 (STN) の深層脳刺激 (DBS) は,パーキンソン病睡眠スケール (PDSS) のスコアで有意な改善を示しています.
- STN- DBSは,パーキンソン病患者の睡眠の全体的な質を顕著に改善します.
結論:
- 非経口療法では,パーキンソン病の夜間症状管理に有効な解決策を提供し,経口薬の限界に対処します.
- サブタラミック核 (STN) の深部脳刺激 (DBS) は,PDにおける睡眠障害を改善するための有望な治療法です.
- パーキンソン病における非運動および睡眠症状に関するDBSと輸液療法の利点を完全に解明するには,さらなる比較研究が必要である.
さらに関連する動画
関連する概念動画
01:24Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375
01:15Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
236
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
236
01:19Management of Insomnia
319
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
319
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123
01:15REM Sleep Behavior Disorder
378
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
378